Investigational Site Number 920 — Los Angeles, California

Investigational Site Number 920 is a clinical research site located in Los Angeles, California, United States 90007-2664.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 920 has participated in 1 clinical trials.

Therapeutic areas: Factor VIII Deficiency.

Sponsors: Bioverativ, a Sanofi company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 920?

Investigational Site Number 920 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 920 conducted?

Investigational Site Number 920 has 1 clinical trials on record. Their work covers Factor VIII Deficiency.

Is Investigational Site Number 920 accredited by Crixeo Health?

Investigational Site Number 920 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 920?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.